US Stock MarketDetailed Quotes

XFOR X4 Pharmaceuticals

Watchlist
  • 0.695
  • +0.063+9.88%
Close Aug 16 16:00 ET
  • 0.680
  • -0.015-2.10%
Post 20:01 ET
117.07MMarket Cap5.34P/E (TTM)

X4 Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

X4 Pharmaceuticals Q2 2024 Earnings Date

Currency：USDAug 8, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
15.27M
563.00K
-14.70M
Miss Est.
--
--
-96.31%
EPS
-<0.01
0.45
+0.46
Beat Est.
+97.88%
+236.36%
+6528.57%
Analyst Rating
Strong Buy

Aug 9, 2024

X4 Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 3.934M--
--2024/Q3-- / 1.686M--
Aug 8, 20242024/Q2563.000K / 15.265M--
May 7, 20242024/Q10.000 / 0.000--
Mar 21, 20242023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 3.934M--
--2024/Q3-- / 1.686M--
Aug 8, 20242024/Q2563.000K / 15.265M--
May 7, 20242024/Q10.000 / 0.000--
Mar 21, 20242023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

X4 Pharmaceuticals Earnings Reports

  • 10-Q: Q2 2024 Earnings Report

    Aug 8 16:15 ET

  • 10-Q: Q1 2024 Earnings Report

    May 7 16:31 ET

  • X4 Pharmaceuticals | 10-K: FY2023 Annual Report

    Mar 21 17:13 ET

  • X4 Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Nov 9, 2023 17:11 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 9, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg